J. Lagier

Publications382
h-index55
Citations13,183
Highly Influential Citations468
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • D. Raoult
  • 2,623 Publications • 106,887 Citations
  • P. Fournier
  • 359 Publications • 16,384 Citations
  • F. Fenollar
  • 367 Publications • 9,719 Citations
  • M. Drancourt
  • 773 Publications • 25,147 Citations
  • Publications
  • Influence
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Abstract Background Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient… Expand
  • 2,891
  • 177
  • PDF
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Objective: to map the literature on mental illness in the general population and in health professionals during the Covid-19 pandemic Method: a scoping review in the MEDLINE / PubMed, SCOPUS, Web of… Expand
  • 531
  • 25
  • PDF
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Abstract Background We need an effective treatment to cure COVID-19 patients and to decrease virus carriage duration.… Expand
  • 434
  • 24
  • PDF
Microbial culturomics: paradigm shift in the human gut microbiome study.
Comprehensive determination of the microbial composition of the gut microbiota and the relationships with health and disease are major challenges in the 21st century. Metagenomic analysis of the… Expand
  • 760
  • 21
Culture of previously uncultured members of the human gut microbiota by culturomics
Metagenomics revolutionized the understanding of the relations among the human microbiome, health and diseases, but generated a countless number of sequences that have not been assigned to a known… Expand
  • 489
  • 12
  • PDF
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Abstract Background In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is used in the treatment of COVID-19.… Expand
  • 262
  • 12
Systemic Tropheryma whipplei: Clinical Presentation of 142 Patients With Infections Diagnosed or Confirmed in a Reference Center
Culture of Tropheryma whipplei, the agent of Whipple disease (WD), was achieved in our laboratory in 2000, allowing new perspectives for the diagnosis of this disease and for the description of other… Expand
  • 149
  • 9
A polyphasic strategy incorporating genomic data for the taxonomic description of novel bacterial species.
Currently, bacterial taxonomy relies on a polyphasic approach based on the combination of phenotypic and genotypic characteristics. However, the current situation is paradoxical in that the genetic… Expand
  • 320
  • 8
Culturing the human microbiota and culturomics
The gut microbiota has an important role in the maintenance of human health and in disease pathogenesis. This importance was realized through the advent of omics technologies and their application to… Expand
  • 189
  • 8
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Abstract Background In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019… Expand
  • 126
  • 8
...
1
2
3
4
5
...